NovoCure (NVCR) Interest Coverage Ratio (2014 - 2026)
NovoCure (NVCR) posted quarterly Interest Coverage Ratio of 1.94 for Q2 2026, up 86.16% year-on-year from 1.04 in Q2 2025, and up 84.58% on a QoQ basis from 12.55 in Q1 2026.
NovoCure (NVCR) Interest Coverage Ratio (2014 - 2026) Analysis & Trends
NovoCure (NVCR) has reported Interest Coverage Ratio for 13 consecutive years, with 1.94 the latest figure, recorded in Q2 2026.
- Quarterly Interest Coverage Ratio rose 86.16% year-over-year to 1.94 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 7.78 (up 49.01% YoY) and the FY2025 annual result came in at 0.08, up 19.46% from the prior year.
- Interest Coverage Ratio rose to 1.94 in Q2 2026 per NVCR's latest filing, from 12.55 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for NVCR reached as high as 0.47 in Q1 2022 and fell as low as 20760.0 in Q1 2024.
- A 5-year average of 1312.63 and a median of 12.35 in 2026 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio sank 27982.46% — and 2025, when it surged 99.93%.
- Year by year, Interest Coverage Ratio stood at 5.3 in 2022, then sank by 98.92% to 10.54 in 2023, then slumped by 134.12% to 24.68 in 2024, then soared by 72.98% to 6.67 in 2025, then jumped by 70.97% to 1.94 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 1.94, 12.55, and 6.67 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.19 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 82.35 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -2.90 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.36 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | NovoCure | 2.28 Bn | 1.85 Bn | 142.48 Mn | -1.94 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.94 |
| Mar 31, 2026 | -12.55 |
| Dec 31, 2025 | -6.67 |
| Sep 30, 2025 | -12.14 |
| Jun 30, 2025 | -13.99 |
| Mar 31, 2025 | -13.57 |
| Dec 31, 2024 | -24.68 |
| Sep 30, 2024 | -10.20 |
| Jun 30, 2024 | -17.05 |
| Mar 31, 2024 | -20,760.00 |
| Dec 31, 2023 | -10.54 |
| Mar 31, 2023 | -73.93 |
| Dec 31, 2022 | -5.30 |
| Sep 30, 2022 | -29.62 |
| Jun 30, 2022 | -9.48 |
| Mar 31, 2022 | -0.47 |
| Dec 31, 2021 | -2.65 |
| Sep 30, 2021 | -4.32 |
| Jun 30, 2021 | -12.60 |
| Mar 31, 2021 | -0.03 |